首页 | 本学科首页   官方微博 | 高级检索  
检索        

癖速消与他莫昔芬联合应用对大鼠乳腺增生的干预作用
引用本文:傅蔓华,徐敏,吉庆明.癖速消与他莫昔芬联合应用对大鼠乳腺增生的干预作用[J].中国实验方剂学杂志,2012,18(12):242-245.
作者姓名:傅蔓华  徐敏  吉庆明
作者单位:1. 河南省中医药研究院,郑州,450004
2. 河南省中医学院,郑州,450000
3. 河南省胸科医院,郑州,450003
基金项目:河南省科技攻关项目(978307)
摘    要:目的:观察癖速消与他莫昔芬联合应用对大鼠乳腺增生的干预作用.方法:随机将大鼠分为正常对照组,模型组,癖速消+他莫昔芬高、中、低(3.0,1.5,0.75 g.kg-1)剂量组,他莫昔芬组1.67 mg· kg-1,癖速消组2.5g·kg-1,大鼠肌注苯甲酸雌二醇0.5 mg.kg-1和黄体酮4 mg.kg -建立大鼠乳腺增生模型,灌胃给药45 d镜下观察大鼠乳腺小叶、腺泡上皮细胞增生和导管扩张等情况;放免法测定血清中雌二醇(E2)和孕酮(P)的含量;免疫组化法检测雌激素受体(ER)及孕激素受体(PR)的表达情况.结果:与模型组比较,癖速消+他莫昔芬能使乳腺增生大鼠乳腺导管及小叶、腺泡上皮细胞增生明显减轻,有显著的统计学差异(P<0.01,P<0.05);能有效的降低大鼠血清中E2,P的含量(P<0.01);可显著抑制乳腺组织ER,PR的表达(P<0.01.P<0.05).结论:癖速消+他莫昔芬对大鼠乳腺增生病理组织学改变有明显的干预作用.

关 键 词:乳腺增生  癖速消  他莫昔芬  雌二醇  孕酮  雌激素受体  孕激素受体
收稿时间:1/8/2012 12:00:00 AM

Protective Effect of Tamoxifen Combined with Pisuxiao in Rats of Mammary Gland Hyperplasia
FU Man-hu,XU Min and JI Qing-ming.Protective Effect of Tamoxifen Combined with Pisuxiao in Rats of Mammary Gland Hyperplasia[J].China Journal of Experimental Traditional Medical Formulae,2012,18(12):242-245.
Authors:FU Man-hu  XU Min and JI Qing-ming
Institution:Henan Academy of Traditional Chinese Medicine, Zhengzhou 450004,China;Henan University of Traditional Chinese Medicine, Zhengzhou 450000,China;Henan Chest Hospital, Zhengzhou 450004,China
Abstract:Objective: To carry out a morphological study on the protective effect of Tamoxifen combined with Pisuxiao in rats of mammary gland hyperplasia. Method: Rat were randomized into 7 groups:nomal,model,Tamoxifen(Tam) with Pisuxiao(PSX,3.0,1.5, 0.75 g·kg-1)and Tamoxifen (1.67 mg·kg-1),Pisuxiao (2.5 g·kg-1),and ig for 45 days.Rat models of of mammary glands hyperplasia were established by intramuscular injection of estradiol benzoate (E2)and progesterone(P). Pathologic histopathology of the breast tissue was check up under the microscope.The estradiol and progesterone contents were determined.Estrogen receptor (ER) and progesterone receptor (PR) were evaluated by immunohistochemical technique. Result: In compare with model groups,the estradiol level of Tam with PSX group was evidently lower than that in the model group, Tamoxifen with Pisuxiao could inhibit the ductal and lobular hyperplasia and induce hyperplasia(P<0.01 or P<0.05), reduce the content of E2 and P in serum (P<0.01).At the sametime ER and PR expressionwere obviously inhibited(P<0.01 or P<0.05). Conclusion: Tamoxifen combined with Pisuxiao is protective in rats withexperimental mammary glands hyperplasia.
Keywords:breast hyperplasia  Pisuxiao  tamoxifen  estradiol benzoate  progesterone  estrogen receptor  progesterone receptor
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号